Paper Details

  1. Home
  2. Paper Details

Comparative effectiveness of glucosamine, chondroitin, acetaminophen or celecoxib for the treatment of knee and/or hip osteoarthritis: a network meta-analysis.

Author: ChuMinjie, JiangLiying, SangLingli, ShenYi, WangYidan, WuDandong, ZhuXiaoyue, ZhuangXun

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Celecoxib was the most effective treatment for pain in patients with knee and/or hip osteoarthritis, followed by a combination of glucosamine and chondroitin. Acetaminophen was the least effective.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To compare the efficacies of oral glucosamine, chondroitin, the combination of glucosamine and chondroitin, acetaminophen and celecoxib on the treatment of knee and/or hip osteoarthritis. METHODS: We searched electronic databases including PubMed, Embase, and Cochrane Library and the re...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/29465368

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Osteoarthritis: Finding the Right Treatment

Osteoarthritis, a condition that affects joints like a relentless desert wind wearing down the sand dunes, is a common problem. This research embarks on a journey through a network of studies to determine the most effective treatments. The researchers meticulously analyzed data from 61 randomized controlled trials, meticulously mapping out the landscape of osteoarthritis therapies. The results, much like a shimmering oasis, reveal that celecoxib, a non-steroidal anti-inflammatory drug, is most effective for pain relief. This knowledge is valuable for healthcare professionals navigating the complex terrain of treating osteoarthritis.

Celecoxib: A Potential Oasis in the Desert of Osteoarthritis Pain

The study, like a compass guiding a traveler through the desert, points to celecoxib as the most effective treatment for osteoarthritis pain. This finding, supported by robust evidence, is significant, as it offers a potential solution for millions suffering from this debilitating condition.

A Camel's Counsel: Choosing the Right Path

While celecoxib emerges as a promising option, remember that every desert journey requires careful consideration. The best treatment for you will depend on individual circumstances and factors like your medical history and potential side effects. Always consult your doctor to find the right path for your health needs.

Dr.Camel's Conclusion

This comprehensive study, like a map guiding a caravan through a vast desert, provides valuable insights into treating osteoarthritis. The researchers have shed light on the effectiveness of various treatment options, highlighting celecoxib as a promising path to pain relief. As a camel who values knowledge, I emphasize the importance of personalized care and consulting your doctor before embarking on any new treatment regimen.

Date :
  1. Date Completed 2018-09-20
  2. Date Revised 2018-09-20
Further Info :

Pubmed ID

29465368

DOI: Digital Object Identifier

12104

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.